Integrating Dermocosmetic Therapy for Acne: Addressing Severity Levels in Real-Life Experiences

January 2025 | Volume 24 | Issue 1 | 88 | Copyright © January 2025


Published online December 11, 2024

doi:10.36849/JDD.8877

Magda Belmontesi MD

Studio Medico Belmontesi, Vigevano, Italy; AGORA' Centro Clinico Formativo, Milan, Italy

Abstract
Background: Acne is prevalent in approximately 80% of individuals aged 11 to 30 years, with scarring occurring in about 40% of cases. Early and sustained treatment is crucial for preventing acne scarring, regardless of severity.
Objectives: The objective of this study was to evaluate skin tolerability and patient compliance after combining a specific dermatologic routine with pharmacological therapy in patients affected by different degrees of acne.
Methods: A comprehensive treatment approach was developed, combining pharmacological therapies in line with established guidelines and a supportive dermocosmetic routine. This routine included a gentle soap-free cleansing emulsion, a moisturizing cream containing glycerin, niacinamide, panthenol, and photoprotection. An anonymous questionnaire was administered to 28 patients (ages 14-31, male and female) to assess their satisfaction and adherence to the treatment plan.
Results: Patient adherence to the therapeutic protocol was found to be essential for achieving expected outcomes. The integration of a specific dermocosmetic routine significantly reduced the risks of erythema, dryness, sensitivity, and retinoid dermatitis, which can lead to treatment interruption and failure. The majority of patients reported high levels of satisfaction with the dermocosmetic products, reinforcing their role in supporting pharmacological treatment.
Conclusion: A holistic approach that integrates personalized dermocosmetological prescription to support pharmacological treatment in the different degrees of acne severity significantly enhances patient adherence and satisfaction, which is essential for successful acne management. By prioritizing adherence to treatment protocols and supporting them with an effective dermocosmetic routine, this strategy ensures better overall outcomes in managing acne.

J Drugs Dermatol. 2025;24(1):88-94. doi:10.36849/JDD.8877

INTRODUCTION

Acne affects approximately 80% of individuals aged 11 to 30 years, with scarring occurring in about 40% of cases.1,2 Early and sustained treatment is crucial for preventing acne scarring in all patients, regardless of acne severity. The three primary degrees of acne - mild/papulo-comedonic, moderate/papulo-pustular, and severe/nodulocystic - guide therapy guidelines, which recommend retinoids as the cornerstone of management during both acute and maintenance phases. To effectively prevent scar formation, a holistic approach is necessary, aiming for an initial treatment that achieves more than 50% clearance of acne lesions and maintenance therapy to prevent relapses through the continued use of topical treatments. Supplementing a pharmacological therapy involving topical retinoids within an appropriate skincare regimen can significantly improve acne management. Conversely, inappropriate skincare practices may lead to increased irritation related to medications, affect sebum production, and potentially exacerbate acne symptoms. A thorough understanding of overall skin health underscores the importance of implementing comprehensive skincare routines in conjunction with pharmacological treatments. This integrated approach not only aims to optimize treatment outcomes but also fosters patient adherence by minimizing adverse effects and promoting skin well-being. Moreover, patient adherence to the therapeutic protocol is vital at all levels of acne severity to achieve the desired outcomes.

Oral Isotretinoin and Topical Retinoids in Acne Treatment
Oral isotretinoin and topical retinoids (e.g., tretinoin, adapalene) or their fixed combinations with benzoyl peroxide can cause significant irritation due to a phenomenon known as "retinoid dermatitis". These retinoids accelerate epidermal cell turnover, leading to thickening of the basal cells in the epidermis and thinning of the corneocyte layer. These changes can alter skin barrier and transepidermal water loss (TEWL).3 As a result, the skin may become more sensitive, particularly during the initial weeks of treatment, leading to various side effects.

The most common signs of sensitive skin are closely linked to impaired barrier function. These include a weakened skin barrier characterized by decreased levels of lipids and